Skip to content
10-Q

Quarterly Report

GE HEALTHCARE TECHNOLOGIES INC. GEHC

0001932393-25-000014

← back to feed
Filed
Apr 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 23, 2025 457.88M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $6.76B
Long Term Debt Q1 2025 · Dec 31, 2024 $7.45B
Short Term Debt Q1 2025 · Mar 31, 2025 $2B
Short Term Debt Q1 2025 · Dec 31, 2024 $1.5B
Cash And Equivalents Q1 2025 · Mar 31, 2025 $2.45B
Cash And Equivalents Q1 2025 · Dec 31, 2024 $2.87B
Stockholders Equity Q1 2025 · Mar 31, 2025 $9.19B
Stockholders Equity Q1 2025 · Dec 31, 2024 $8.45B
Current Liabilities Q1 2025 · Mar 31, 2025 $9.97B
Current Liabilities Q1 2025 · Dec 31, 2024 $9.55B
Total Liabilities Q1 2025 · Mar 31, 2025 $24.17B
Total Liabilities Q1 2025 · Dec 31, 2024 $24.44B
Current Assets Q1 2025 · Mar 31, 2025 $9.74B
Current Assets Q1 2025 · Dec 31, 2024 $9.9B
Total Assets Q1 2025 · Mar 31, 2025 $33.59B
Total Assets Q1 2025 · Dec 31, 2024 $33.09B
Shares Diluted Q1 2025 · Mar 31, 2024 459M sh
Dividends Paid Q1 2025 · Mar 31, 2024 $14M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $419M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.81
Eps Basic Q1 2025 · Mar 31, 2024 $0.82
Sga Expense Q1 2025 · Mar 31, 2024 $1.04B
Rd Expense Q1 2025 · Mar 31, 2024 $324M
Net Income Q1 2025 · Mar 31, 2024 $374M
Operating Income Q1 2025 · Mar 31, 2024 $540M
Gross Profit Q1 2025 · Mar 31, 2024 $1.9B
Revenue Q1 2025 · Mar 31, 2024 $4.65B